CareFusion hit with Class I notice for pump recall
This article was originally published in Clinica
Executive Summary
CareFusion’s recall of 17,000 Alaris PC intravenous pumps has been given a Class I notification from the US FDA. CareFusion noticed that the pumps could suffer a communication error under certain wireless conditions and sent an urgent recall notice to its customers on 24 August. The error may result in a delay of therapy and an inability to make programming changes to the current infusion settings. This, in turn, could lead to adverse health consequences or death. CareFusion (San Diego, California) is conducting a field corrective action to update the hardware on the affected units which were manufactured or serviced between December 2008 and September 2009. The firm has recorded a reserve charge in its 2010 fiscal fourth quarter for all the actions related to the corrective action plan.
You may also be interested in...
Alere aided by professional diagnostics sales in fourth quarter
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra and Stout to work on expandable interbody device
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe eyes portfolio expansion to help boost molecular diagnostics credentials
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals